Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.15 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.348EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.575EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.4 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.442EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.1 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used